Pembrolizumab plus lenvatinib in women with advanced or recurrent uterine carcinosarcoma.

Authors: Qi Wendel Zhang, Jubilee Brown, Erin Crane, Yovanni Casablanca, R. Wendel Naumann

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17625

Source: Full article

---

Abstract

e17625